907 results found | searching for "pharma"

• 
• Are you finding the best ayurvedic medicine manufacturer in North India? We are here to assist you! Yamuna Pharmacy is the leading manufacturer and provides ayurvedic and herbal products distributorship. Visit now at https://yamunapharmacy.com/ [more]

  by yamunapharmacy,  Health 

  0 reply
• 
• The Tissue Engineering-based Regeneration Products market is projected to grow at a CAGR of 9.17%, till 2035, claims Roots Analysis The present treatment landscape of chronic wound and bone healing is characterized by a variety of unmet needs; tissue engineering-based regeneration products have emerged as a viable therapeutic option, which is capable of catering to the growing demand Roots Analysis has announced the addition of “Tissue Engineering-based Regeneration Products Market, 2022-2035” report to its list of offerings. Given the ever-increasing demand for tissue transplantation, primarily for wound and bone healing, there is an urgent need for safe and efficient products that enable healing and regeneration. At present, the supply of tissue donations is insufficient to satisfy the required demand. It is worth highlighting that, in recent years, tissue engineering and regenerative medicine have emerged as promising alternatives for tissue regeneration. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/tissue-engineering-market/request-sample.html Key Market Insights Over 115 tissue engineering-based skin regeneration products are presently available in this market space About 50% of the total products are intended for wound healing, followed by developed for the purpose of surgical healing. Further, more than 50% of the products are made of human placental tissues, followed by those developed using other animal-based tissues. ~40 tissue engineering-based bone regeneration products are being offered by developers, globally About 55% of the total products are made from bone tissues, followed by those developed using stem cells. In fact, most of the products are formulated in the form of a sheet (10), followed by those developed in the form of a bone matrix. Further, nearly 75% of the products are available in the form of xenografts. Around 60 players are engaged in the development of the tissue engineering-based regeneration products Majority of the players engaged in this domain are mid-sized firms (51-500 employees, 31%), followed by small players (11-51 employees, 27%), large players (1000-5000 employees, 26%) and very small (2-10 employees, 10%) companies. It is worth noting that ~40% developers are based in North America. Till date, 750+ grants have been awarded for tissue engineering-based regeneration products For research and development activity of tissue engineering-based regeneration products, grant amount of close to USD 300 million has been awarded in last five years. Further, 70% of this amount was awarded in 2021 alone. Patent activity in this domain has grown at a CAGR of ~11%, between 2012 and 2022 R&D activity related to tissue engineering-based regeneration products is largely concentrated in North America; this can be validated from the fact that about 40% of the total patents were filed in this region, followed by the World Intellectual Property Organization (30%) and Asia-Pacific region (20%). More than USD 2 billion Invested by industry and non-industry stakeholders in the last five years Majority of the companies primarily received funding through private placements (~25%) and debt financing (~20%) rounds. It is worth mentioning that, over 95% of the amount was invested in companies based in North America. Partnership activity in this domain has increased at a CAGR of ~25%, between 2017 and 2022 Large companies have inked the highest number of partnerships related to tissue engineering-based regeneration products, In addition nearly 40% majority of the agreements reported in tissue engineering market were instances of mergers and acquisitions. North America is expected to capture more than 55% share in the tissue engineering-based regeneration products market by 2035 In terms of area of application, the current market is anticipated to be driven by products intended for skin healing (~50%), followed by those targeting bone healing (~30%). Further, xenograft-based products are expected to grow at a relatively faster pace (10.58%), till 2035. Key Questions Answered  Who are the leading players engaged in providing tissue engineering-based regeneration products?  Which tissue engineering-based regeneration product is most commonly offered by developers?  What is the relative competitiveness of tissue engineering-based regeneration product providers?  What types of partnership models are commonly being adopted by stakeholders in this industry?  What is the trend for capital investments in the tissue engineering-based regeneration products market?  How has the patent landscape in this domain evolved over the last two decades?  What is the overall trend of grant activity related to tissue engineering-based regeneration products?  Which key market trends and driving factors are likely to impact the growth of the tissue engineering-based regeneration products market?  How is the current and future market opportunity likely to be distributed across key market segments? The financial opportunity within the tissue engineering-based regeneration devices has been analyzed across the following segments:  Type of Graft  Allografts  Autografts  Xenografts  Area of Application  Bone Healing  Burn Healing  Wound Healing  Surgical Healing  Others  Key Geographical Regions  Ambulatory Surgical Centers  Hospitals  Specialty Clinics  Key Geographical Regions  North America  Europe  Asia  Middle East and North Africa  Latin America  Rest of the World The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its recent developments (including funding and collaborations) and an informed future outlook.  AlloSource  Bio-Tissue  Integra LifeSciences  MiMedx  Organogenesis  Smith+Nephew  Tissue Regenix  VIVEX Biologics For additional details, please visit https://www.rootsanalysis.com/reports/tissue-engineering-market.html You may also be interested in the following titles: 1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035 2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com [more]

  by jameshebrew,  Health 

  0 reply
• 
• You can go for the right Medicare supplement plan in case you want to fill the "gap" left by way of the Original Medicate plan. This is the motive it is also known as Medigap plans. These styles of insurance rules are supplied by means of personal insurance businesses. The purpose of those policies is to offer coverage for copayments, coinsurance, and deductibles, just to name a few. In this newsletter, we have shared some easy guidelines that will help you choose the nice plan to satisfy your wishes. Read on to find out more. 1. Find out About the Available Plans on your State First of all, it is critical to remember the fact that all the plans are standard, which means all of them offer the equal degree of insurance. But it is as much as coverage providers to determine on the plans that they need to offer. For example, an insurance issuer may also pick to offer to a few plans in unique states. Therefore, you could want to do your homework and compare exceptional rules. https://medicineexpert.com/forums/forum/internal-medicine-forum/4527-fitness https://www.dibiz.com/kjy2vace https://promosimple.com/ps/254ed/way-to-health https://kjyvace.contently.com/ http://bioimagingcore.be/q2a/787098/ecosystem-that-allowed https://pharmatalk.org/read-blog/35452 http://www.renexus.org/network/read-blog/151394 http://networks786.ovh/read-blog/75036 https://www.b-webdesign.org/dir-wowonder/read-blog/151555 https://healthss.hashnode.dev/health-cares https://schriurm-slaurth-pheost.yolasite.com/ https://wakelet.com/wake/0EUdza5XZEyH895_1l8in [more]

  by wmupsvfg,  Health 

  0 reply
• 
• Pharma Franchise for Antihypertensive Medicine - Martyn Nikk Martyn Nikk Pharmaceutical offers S Dip-2.5 tabets which contain S-Amlodipine 2.5mg salt that is basically is used to treat hypertension (high blood pressure) and angina (chest pain). We offer for PCD Pharma Franchise on monopoly across India. http://martynnikk.com/p/s-dip-25 [more]

  by martynnikkpharma,  Other - Health 

  0 reply
• 
• The global generic injectables market size was valued at USD 83.09 billion in 2021 and is poised to grow at a significant CAGR of 12.2% during the forecast period 2022-28. Identical to its branded predecessor in strength, dosage form, security, performance, quality, planned use, adverse effects, and method of administration, a generic injectable is a medication that is manufactured with the same active pharmaceutical component. It is utilized to quickly administer the medication into the body and is equally safe and effective as an innovative drug. It makes liquid medications easier to absorb, reducing the amount of dosage administration without compromising the effectiveness of the medicine.

  by bhavana,  Other - Health 

  0 reply
• 
• The global health diaphragm valves market size was valued at a USD x bn in 2021, poised to grow at significant CAGR of 6.6% during the forecast period 2022-2028. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on. The research report “Health Diaphragm Valves Market: By Product Type (Electric Diaphragm Valves, Manual Diaphragm Valves, Pneumatic Diaphragm Valves, Others), By End User (Pharmaceutical and Biopharmaceutical Industries, Biotechnology Industries, Food Industries, Others) and -Global/Region/Country Forecast to 2028.”

  by bhavana,  Other - Health 

  0 reply
• 
• Are you dealing with blemishes or acne? Not to worry! Yamuna Pharmacy has developed Stams, best blood purifier syrup to help you avoid infections. Place your order now at https://yamunapharmacy.com/product/stams-syrup-best-blood-purifier-syrup/ [more]

  by yamunapharmacy,  Health 

  0 reply
• 
• LIPOSOME – A TRENDING NOVEL DRUG DELIVERY SYSTEM In recent years, liposomes have garnered significant interest of researchers, as well as industry players, owing to their potential in diagnosis and treatment of various diseases, with a focus on delivering drugs and genetic material. Liposomes are small, artificial and lipid-based bilayered spherical vesicles, which are created spontaneously by hydrated phospholipids. Owing to their ability to encapsulate bioactive hydrophilic, amphipathic, and lipophilic molecules, liposomes are extensively used as efficient delivery systems for antigens or drugs. They can protect a drug from being detected by the body’s immune system by imitating biological membranes and providing the drug more time to reach its target destination. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/liposome-manufacturing-market/request-sample.html Liposomes offer great therapeutic efficacy and safety. They have several applications in the biomedical field such as delivering drug to the desired site while minimizing drug exposure to normal tissues, increased delivery of potential medications to the cytosol, stabilizing therapeutic compounds, and removing barriers to cellular and tissue absorption. In addition to the applications, liposomes are gaining popularity across various other fields, including drug delivery, agriculture, cosmetics, and food industry. Due to multiple advantages across diverse application areas, including enhanced biocompatibility, high biodegradability, low toxicity, weak immunogenicity, increased drug solubility, controlled distribution, ability to make surface modifications for targeted, extended, and sustained release, liposomes have been recognized as the most effective delivery system. Currently, there are several liposomal formulations clinically approved for the treatment of various diseases, including cancer, fungal and viral infections, and many are currently in advanced stages of clinical studies. Over the years, several companies involved in the development of liposomes have made significant efforts in conducting clinical trials for evaluating the efficacy of liposome-based therapeutics, for the treatment of various oncological disorders. Owing to various advantages offered by liposomes, advanced liposome technology is being developed to fully substructure the therapeutic applications of liposomes and extensive research is being conducted to develop methods for liposomal formulation with high level of purity and sensitivity. Further, it is extremely desirable to develop novel manufacturing methods that allow for simple encapsulation of both hydrophobic and hydrophilic molecules without the need of organic solvents, specialized equipment, or complex infrastructures. Additionally, given that liposomes have demonstrated some clinical promise as drug delivery systems, future efforts should focus on enhancing the commercial availability and accessibility of liposome products across the globe, particularly in low- and middle-income countries. applications of liposomes in drug delivery (24%), and protein and peptide delivery (9%), which is indicative of the extensive research activities and clinical trials being conducted to evaluate the therapeutic potential of liposomes. Despite several advancements, there are various challenges in development of liposomes, for which stakeholders are leveraging the expertise of various contract service providers offering development and manufacturing services. These service providers are actively upgrading their capabilities and infrastructure to accommodate the demand for these vesicles. Driven by the growing research efforts, development of advanced methods for preparation and characterization of liposomes, and efforts of various stakeholders, this segment of industry is likely to witness noteworthy growth in the foreseen future. For additional details, please visit https://www.rootsanalysis.com/reports/liposome-manufacturing-market.html You may also be interested in the following titles: 1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035 2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com [more]

  by jameshebrew,  Health 

  0 reply
• 
• https://precisionbusinessinsights.com/market-reports/traumatic-brain-injury-treatment-market/ Traumatic Brain Injury Treatment Market: By Treatment Type (Drugs, Surgery), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography

  by vamshee,  Health 

  0 reply
• 
• Top Vitamin D3 & Calcium Softgel Capsule Welco-D3 Martyn Nikk Pharmaceutical offers Welco-D3 softgel capsule which is basically is used in the treatment of vitamin D deficiency and osteoporosis. http://martynnikk.com/p/welco-d3-softgel-capsules [more]

  by martynnikkpharma,  Other - Health 

  0 reply